Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lidocaine enhances Galphai protein function.

Claudia Benkwitz1, James C Garrison, Joel Linden

  • 1Department of Anesthesiology, University of Virginia, Charlottesville, Virginia, 22908-0710, USA.

Anesthesiology
|October 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenosine A2A and A2B receptor signaling in neurons promotes glucose and fatty acid release in the postprandial state.

bioRxiv : the preprint server for biology·2026
Same author

Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trial.

JTCVS open·2025
Same author

Computer vision digitization of smartphone images of anesthesia paper health records from low-middle income countries.

BMC bioinformatics·2024
Same author

G protein β<sub>4</sub> as a structural determinant of enhanced nucleotide exchange in the A<sub>2A</sub>AR-Gs complex.

Research square·2024
Same author

Unlocking antitumor immunity with adenosine receptor blockers.

Cancer drug resistance (Alhambra, Calif.)·2024
Same author

1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A<sub>2B</sub> Adenosine Receptors.

Drug development research·2024
Same journal

The Time-out.

Anesthesiology·2026
Same journal

Evaluation of Post-block Hypersensitivity Using Quantitative Sensory Testing Before, During, and After Axillary Brachial Plexus Block Resolution in Healthy Volunteers.

Anesthesiology·2026
Same journal

The state of medical education research in Anesthesiology: Current landscape and future directions - An initiative of the Anesthesia Research Council.

Anesthesiology·2026
Same journal

Diagnostic Ultrasound-guided Focused Ultrasound-induced Noninvasive, Reversible Peripheral Nerve Blockade in an In Vivo Model of Acute Pain: A Proof-of-Concept Study.

Anesthesiology·2026
Same journal

S-Ketamine Reduces Risk of Postoperative Delirium: Comment.

Anesthesiology·2026
Same journal

Computed Tomography-Based Body Composition Assessment for Preoperative Cardiovascular Risk Prediction: A Prospective Cohort Study.

Anesthesiology·2026
See all related articles

Local anesthetics like lidocaine enhance signaling of G alpha i-coupled adenosine 1 receptors by reducing cyclic AMP. This suggests G alpha i proteins are a key target for local anesthetic action.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Local anesthetics (LAs) are known to inhibit G protein-coupled receptors (GPCRs) via Galphaq interaction.
  • The effect of LAs on other G protein classes, particularly Galphai, remains unclear.
  • Adenosine 1 receptors (A1Rs), coupled to Galphai, are abundant in the central nervous system and heart, suggesting potential clinical relevance.

Purpose of the Study:

  • To investigate the interaction of lidocaine with the human adenosine 1 receptor (hA1R)-coupled signaling pathway.
  • To determine if lidocaine affects hA1R function and its downstream signaling cascade.
  • To elucidate the specific site of action for lidocaine within the Galphai signaling pathway.

Main Methods:

  • Stable expression of hA1Rs in Chinese hamster ovary cells.

Related Experiment Videos

  • Assays for cyclic adenosine monophosphate (cAMP) levels, receptor binding, and G protein activation (GDP/GTP gamma35S exchange).
  • Utilized phosphodiesterase inhibitor rolipram and pertussis toxin to dissect signaling components.

    • Main Results:

    • Lidocaine did not affect agonist/antagonist binding to hA1R or receptor-G protein interactions.
    • Lidocaine significantly reduced cAMP levels by 50% independently of A1R activation.
    • This reduction was unaffected by rolipram but abolished by pertussis toxin, indicating a target upstream of adenylate cyclase and involving Galphai.

    Conclusions:

    • Lidocaine potentiates Galphai-coupled A1R signaling by decreasing cAMP production.
    • The Galphai protein is identified as a primary target site for lidocaine's action in this pathway.
    • These findings support the hypothesis that specific G protein subunits are alternative sites of local anesthetic action, extending beyond Galphaq.